If you’ve started exploring therapy for OCD, you’ve likely come across different approaches. There's exposure and response ...
Texas is helping shape the future of psychedelic therapies. Here’s how they work and what access could look like.
Edward G. Neilan from NORD discusses critical efforts to speed up therapy development for rare diseases lacking treatments ...
A two-axis model links affordability pressure with clinical/logistical complexity to identify fit-for-purpose channels rather ...
New BPEI preclinical data address treatment protocol, corneal biochemical environment, fungal resistance mechanism, MRSA biofilm inhibition, and ...
The European Parliament on Wednesday voted in favor of banning so-called conversion therapy across the European Union. ACT (Against Conversion Therapy) LGBT in 2024 launched a campaign in support of ...
New BPEI preclinical data address treatment protocol, corneal biochemical environment, fungal resistance mechanism, MRSA ...
Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research ...
The president's facilitation of research and FDA review could help make psychedelics available to approved patients. But what about everyone else?
Tennessee lawmakers voted to allow studies of psychedelic drugs to treat veterans, days after Trump's executive order to fast ...
STOCKHOLM, SE / ACCESS Newswire / May 5, 2026 / Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (NASDAQ Stockholm:EGTX) today announced that the United States Patent and Trademark Office (US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results